Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 3, 2007, Pages 655-657

  Aragón, Lina Marcela ^a   Garrigó, Montserrat ^a,b   Moreno, Carmen ^a   Español, Montserrat ^a   Coll, Pere ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Resistance; Susceptibility testing; Tuberculosis

Indexed keywords

BACTERIAL PROTEIN; PNCA PROTEIN; PYRAZINAMIDE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DIAGNOSTIC KIT; HUMAN; INTERMETHOD COMPARISON; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

AMIDOHYDROLASES; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE; TUBERCULOSIS;

EID: 34548131201     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm252     Document Type: Article

References (8)

1. Zhang Y, Mitchison D. The curious characteristics of pyrazinamide: A review. Int J Tuberc Lung Dis 2003; 7: 6-21.
2. Siddiqi SH. BACTEC 460 TB' System. Product and Procedure Manual, Revision D. Sparks, MD: Becton Dickinson Microbiology Systems, 1995.
3. National Committee for Clinical Laboratory Standards. Susceptibility Testing of Mycobacteria, Nocardiae and Other Aerobic Actinomycetes: Approved Standard M24-A. NCCLS, Villanova, PA, USA, 2004.
4. Somoskovi A, Dormandy J, Parsons LM. et al. Sequencing of the pncA gene in members of the Mycobacterium tuberculosis complex has important diagnostic applications: Identification of a species-specific pncA mutation in Mycobacterium canettii, and the reliable and rapid predictor of pyrazinamide resistance. J Clin Microbiol 2006; 45: 595-9.
5. Barco P, Cardoso RF, Hirata RD et al. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil. J Antimicrob Chemother 2006; 58: 930-5.
6. Bemer P, Bodmer T, Munzinger J et al. Multicenter evaluation of the MB/BACT system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2004; 42: 1030-4.
7. Singh P, Wesley C, Jadaun G P et al. Comparative evaluation of pyrazinamide susceptibility testing of Mycobacterium tuberculosis by Lowenstein Jensen proportion method, BacT/ALERT 3D system, and enzymatic pyrazinamidase assay. J Clin Microbiol 2006; 45: 76-80.
8. Barreto AM, Araulo JB, de Melo Medeiros RF et al. Evaluation of indirect susceptibility testing of Mycobacterium tuberculosis to the first- and second-line, and alternative drugs by the newer MB/BacT system. Mem Inst Oswaldo Cruz 2003; 98: 827-30.